Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.30B | 2.66B | 2.81B | 2.07B | 2.33B |
Gross Profit | 384.08M | 351.98M | 339.69M | 253.02M | 241.60M |
EBITDA | 217.32M | 198.40M | 175.04M | 123.25M | 62.49M |
Net Income | 78.78M | 82.85M | 65.50M | 1.67M | -90.31M |
Balance Sheet | |||||
Total Assets | 2.65B | 2.96B | 3.37B | 2.96B | 2.73B |
Cash, Cash Equivalents and Short-Term Investments | 145.30M | 147.49M | 188.93M | 119.10M | 135.87M |
Total Debt | 1.29B | 1.44B | 1.52B | 1.46B | 1.44B |
Total Liabilities | 1.61B | 1.88B | 2.25B | 1.95B | 1.82B |
Stockholders Equity | 940.57M | 961.15M | 990.84M | 887.72M | 805.85M |
Cash Flow | |||||
Free Cash Flow | 182.05M | 420.00K | 69.59M | 76.42M | 69.19M |
Operating Cash Flow | 192.24M | 3.20M | 78.69M | 78.62M | 78.85M |
Investing Cash Flow | -21.99M | -10.81M | -19.54M | -20.55M | -25.10M |
Financing Cash Flow | -170.60M | -31.89M | 9.80M | -60.53M | -57.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | HK$260.84M | 2.95 | 9.24% | 17.56% | -19.85% | -8.43% | |
58 Neutral | HK$252.45M | 461.11 | 1.12% | ― | -24.68% | -89.16% | |
56 Neutral | HK$2.69B | 4.98 | -9.32% | 8.09% | 12.55% | -102.16% | |
53 Neutral | HK$321.68M | ― | -25.78% | 1.01% | -37.98% | -176.24% | |
― | $31.41M | ― | ― | ― | ― | ||
46 Neutral | HK$149.99M | ― | -0.58% | ― | -22.84% | -103.13% | |
42 Neutral | HK$32.40M | ― | -12.68% | ― | -55.96% | -286.09% |